The "Influenza Diagnostics Market by Test Type, by End-user, Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
Influenza is a highly contagious disease caused by the influenza virus attacking the respiratory system - lungs, nose, and throat, which causes illness. This can also lead to the death of the infected person. Influenza diagnostics tests enable to identify the virus in the body.
The Influenza Diagnostics Market is predicted to grow at a CAGR of 6.3% during the forecasting period market is expected to grow from $4.0 billion in 2020 to a value of $5.8 billion in 2026. The Influenza Diagnostics Market study is segmented by test type, end-user, and geography.
Majorly, the RIDT diagnostic test in traditional diagnostics test is the most demanding segment based on the test type due to simple usage procedure and the low cost of diagnosis. Moreover, it is significant in the situation of a low-resource setting and also easy to read and less time-consuming procedure. Hence, the RIDT diagnostic test segment has the largest share in the influenza diagnostics market.
The majority of the influenza diagnostics market share is acquired by the hospital segment based on the end-users. However, the influenza tests are frequently carried by the hospitals due to its complicated nature and also require advanced technology products to carry the influenza diagnosis.
As per the geographical analysis, the market is segmented by North America, Europe, Asia Pacific, and the rest of the world. Compared to the other regions, North America has acquired the largest share in the market due to the rising incidence of respiratory diseases such as influenza and the increasing demand for the influenza screening test in this region. Asia Pacific region is estimated to have the fastest growth in the market with the rapidly increasing population, which is leading to the spread of contagious diseases while the government is stepping up its initiatives to reduce the spread of contagious diseases.
Globally, the contagious diseases are increasing; hence, the influenza diagnostics enable to identify influenza the most contagious disease. Majorly two factors emphasizing the influenza diagnostics market growth are the increasing elderly population as the old generation is weak, and lack of immunity can cause influenza and the increasing investments in influenza diagnostic research. Somehow, the rising cost of kits and reagents in the influenza diagnostics is the major aspect hindering the market growth.
Companies Mentioned
- Quidel Corporation Inc
- Abbott Laboratories Inc.
- Hologic Inc
- Becton
- Dickinson and Company
- Danaher CORPORATION
- Diasorin sa
- Meridian Bioscience
- Luminex Corporation
- Biomerieux sa
- Genmark Diagnostics Inc
- Siemens Healthineers
- Thermo Fisher Scientific
- Tecan Trading
- Sekisui Diagnostics
- F. Hoffmann-la Roche AG
- SA Scientific Ltd
- Altona Diagnostics GMBH
- Coris Bioconcept SPRL and Elitech Group.
Key Topics Covered:
1. Executive Summary
2. Industry Outlook
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. End-user: Market Size & Analysis
5.1. Overview
5.2. Traditional Diagnostic Tests
5.2.1. RIDT
5.2.2. Viral Culture
5.2.3. DFA
5.2.4. Serological assays
5.3. Molecular Diagnostic Tests
5.3.1. RT-PCR
5.3.2. INNAT
5.3.2.1. TMA
5.3.2.2. LAMP
5.3.2.3. NASBA
5.3.2.4. Other INNAT
5.3.3 Other Molecular Tests
6. End-User: Market Size & Analysis
6.1. Overview
6.2. Hospitals
6.3. Clinical Laboratories
6.4. Other End-User
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.3. Mergers and Acquisitions, Legal, Awards, Partnerships
8.4. Product Launches and execution
9. Vendor Profiles
10. Companies to Watch
11. Analyst Opinion
12. Annexure
For more information about this report visit https://www.researchandmarkets.com/r/3bjr7j
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005665/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
